4,995
edits
No edit summary |
|||
Line 20: | Line 20: | ||
* [[Ketogenic diet|Keto friendly]] foods with [https://wikimd.com/wiki/W8MD_weight_loss_diet online keto recipes]. | * [[Ketogenic diet|Keto friendly]] foods with [https://wikimd.com/wiki/W8MD_weight_loss_diet online keto recipes]. | ||
== News == | |||
The U.S. Food and Drug Administration (FDA) recently approved Zepbound (tirzepatide) for chronic weight management. Here are the key details about this new medication: | |||
Approval Date and Purpose: The FDA approved Zepbound on November 8, 2023. It is intended for chronic weight management in adults with obesity or those who are overweight with at least one weight-related comorbid condition. | |||
Indications and Usage: Zepbound is approved as an adjunct to a reduced-calorie diet and increased physical activity for managing weight in adults. It is specifically indicated for those with a body mass index (BMI) of 30 kg/m² or greater (classified as obesity) or a BMI of 27 kg/m² or greater (classified as overweight) who also have at least one weight-related comorbidity. | |||
Dosage and Availability: The medication is available in various dosages, including 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. These doses can be accessed through a prescription and are available at retail and mail-order pharmacies. | |||
Background of the Medication: Zepbound is a new version of Eli Lilly’s Mounjaro, which was previously approved by the FDA for controlling blood sugar in people with Type 2 diabetes. This marks an expansion in the use of tirzepatide, the active ingredient in Zepbound, beyond diabetes management to include weight management. | |||
W8MD weight loss centers offers Zepbound and other weight loss injections and medications, both brand names and generic when available. [https://www.wikimd.com/wiki/Zepbound Learn more...] | |||
'''Lose weight, sleep well and look your best with W8MD!'''</h3> | '''Lose weight, sleep well and look your best with W8MD!'''</h3> | ||
|} | |} |